Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Mar 25;12(1):121.
doi: 10.1038/s41398-022-01877-2.

Characterizing mood disorders in the AFFECT study: a large, longitudinal, and phenotypically rich genetic cohort in the US

Collaborators, Affiliations

Characterizing mood disorders in the AFFECT study: a large, longitudinal, and phenotypically rich genetic cohort in the US

Maria Dalby et al. Transl Psychiatry. .

Abstract

There has recently been marked progress in identifying genetic risk factors for major depression (MD) and bipolar disorder (BD); however, few systematic efforts have been made to elucidate heterogeneity that exists within and across these diagnostic taxa. The Affective disorders, Environment, and Cognitive Trait (AFFECT) study presents an opportunity to identify and associate the structure of cognition and symptom-level domains across the mood disorder spectrum in a prospective study from a diverse US population.Participants were recruited from the 23andMe, Inc research participant database and through social media; self-reported diagnosis of MD or BD by a medical professional and medication status data were used to enrich for mood-disorder cases. Remote assessments were used to acquire an extensive range of phenotypes, including mood state, transdiagnostic symptom severity, task-based measures of cognition, environmental exposures, personality traits. In this paper we describe the study design, and the demographic and clinical characteristics of the cohort. In addition we report genetic ancestry, SNP heritability, and genetic correlations with other large cohorts of mood disorders.A total of 48,467 participants were enrolled: 14,768 with MD, 9864 with BD, and 23,835 controls. Upon enrollment, 47% of participants with MD and 27% with BD indicated being in an active mood episode. Cases reported early ages of onset (mean = 13.2 and 14.3 years for MD and BD, respectively), and high levels of recurrence (78.6% and 84.9% with >5 episodes), psychotherapy, and psychotropic medication use. SNP heritability on the liability scale for the ascertained MD participants (0.19-0.21) was consistent with the high level of disease severity in this cohort, while BD heritability estimates (0.16-0.22) were comparable to reports in other large scale genomic studies of mood disorders. Genetic correlations between the AFFECT cohort and other large-scale cohorts were high for MD but not for BD. By incorporating transdiagnostic symptom assessments, repeated measures, and genomic data, the AFFECT study represents a unique resource for dissecting the structure of mood disorders across multiple levels of analysis. In addition, the fully remote nature of the study provides valuable insights for future virtual and decentralized clinical trials within mood disorders.

PubMed Disclaimer

Conflict of interest statement

The study was funded by H. Lundbeck A/S and the Milken Institute. MD, MV, NP, and LH-H are employees of H. Lundbeck A/S. DH, YJ, CTT, DD, CHW, and members of the 23andMe Research Team are employees of 23andMe, Inc. JWS is a member of the Leon Levy Foundation Neuroscience Advisory Board and received an honorarium for an internal seminar at Biogen, Inc.

Figures

Fig. 1
Fig. 1. Flowchart illustrating the enrollment.
The procedural steps were: Informed consent, apply for enrollment and meet study inclusion and no exclusion criteria, return a saliva kit for genotyping (except for excisting costumers who purchased and returned a 23andMe kit prior to joining the study), and answer the baseline questionnaire. In the 9 months after enrolment, participants were asked to complete monthly surveys and cognitive tests.
Fig. 2
Fig. 2. Baseline clinical features.
A Summary of key clinical features in cases reporting a diagnosis of MDD, BD subtype 1 (BD1) and BD subtype 2 (BD2), as per latest diagnosis recieved. Mood disorders cases in this 23andMe sub-cohort show high burdens of illness. Any medication class refers to medication received over the last 5 years and during the study. Percentage of those who answered one or several treatment questions in the medication survey. B Transdiagnostic symptoms. Radar plot of median score pr. symptom domain within controls (purple), MD (blue), and BD (orange) participants. Scores are based on the DSM-5 cross-cutting symptom measures, where max item score (ranging from 0 to 4) within each domain is reported and summarized.
Fig. 3
Fig. 3. Genetic component.
A Liability-scale SNP-heritability of AFFECT BD and MD as a function of population prevalence, ranging from 0.001 to 0.03 for BD and 0.001–0.3 for MD with rg estimates at every 0.001 step-wise increase. Dotted line represents s.e. B Estimated genetic correlations of European ancestry AFFECT BD and MD with PGC GWAS of MDD3 (excluding the 23andMe cohort), the 23andMe MD discovery cohort (Hyde et al, 2016), PGC-BD2, and of PGC-BD3, which is further divided into BD3 type I and type II. Correlations in AFFECT BD were performed with the full cohort (BD) and within BD type (BD1, BD2). All correlations were significant, circle size and values indicate rg. P-values, Z-scores and s.e are reported in Supplementary Table 9.

References

    1. Sklar P, Ripke S, Scott LJ, Andreassen OA, Cichon S, Craddock N, et al. Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4. Nat Genet. 2011;43:977–85. doi: 10.1038/ng.943. - DOI - PMC - PubMed
    1. World Health Organization. Depression and Other Common Mental Disorders—Global Health Estimates. World Health Organization; 2017. p24.
    1. Romera I, Perez V, Menchón JM, Delgado-Cohen H, Polavieja P, Gilaberte I. Social and occupational functioning impairment in patients in partial versus complete remission of a major depressive disorder episode. A six-month prospective epidemiological study. Eur Psychiatry. 2010;25:58–65. doi: 10.1016/j.eurpsy.2009.02.007. - DOI - PubMed
    1. Rosa AR, Reinares M, Michalak EE, Bonnin CM, Sole B, Franco C, et al. Functional Impairment and Disability across Mood States in Bipolar Disorder. Value Heal. 2010;13:984–8. doi: 10.1111/j.1524-4733.2010.00768.x. - DOI - PubMed
    1. Sullivan PF, Neale MC, Kendler KS. Genetic epidemiology of major depression: Review and meta-analysis. Am J Psychiatry. 2000;157:1552–62. doi: 10.1176/appi.ajp.157.10.1552. - DOI - PubMed

Publication types

MeSH terms